Browsing by Autor "Bianca Limpias Terceros"

Now showing 1 - 3 of 3

Temáticas de la producción científica de la revista cubana de farmacia indizada en scopus (1967-2020)
(Editorial Ciencias Médicas, 2021) Sun Ah Chung; Selma Olivera; Brenda Rojas Román; Evelyn Alanoca; Stephanie Moscoso; Bianca Limpias Terceros; Aldo Álvarez-Risco; Jaime A. Yáñez
Introduccion: La Revista Cubana de Farmacia cumplio este ano su quincuagesimo cuarto aniversario, durante el cual ha publicado con exito, hasta el 2020, mas de 1110 trabajos indizados en la base de datos bibliografica Scopus. Objetivo: Describir la produccion cientifica desde el punto de vista tematico de la Revista Cubana de Farmacia indizada en Scopus. Metodos: Se realizo un estudio cualitativo, a partir de la revision sistematica de la literatura cientifica publicada por la Revista Cubana de Farmacia , disponible en Scopus. Se agruparon las publicaciones por areas tematicas de acuerdo al criterio de los autores, sobre la base de las palabras clave presentadas en los resumenes y el tema central del articulo. Las areas tematicas definidas fueron ocho, con siete subtemas. Conclusiones: Desde 1967, la Revista Cubana de Farmacia se ha esforzado por promover el avance de la ciencia y la investigacion en su pais de origen, Cuba. La variedad de sus articulos resulta de gran valor para investigadores y estudiantes extranjeros. Los estudios presentados se han caracterizado por la diversidad de temas relacionados con la farmacologia, el uso de plantas medicinales cubanas con fines terapeuticos y la metodologia para una mejor elaboracion de farmacos y procedimientos de laboratorios.
Tratamiento de la COVID-19 en Perú y Bolivia y los riesgos de la automedicación
(LA Referencia, 2020) Brenda Rojas Román; Stephanie Moscoso; Sun Ah Chung; Bianca Limpias Terceros; Aldo Álvarez-Risco; Jaime A. Yáñez
Introduction: Various drugs are being used against the symptoms caused by COVID-19, without being approved for these purposes. Many of these drugs have small safety margin and very risky adverse effects on health, a reason why they require prescription and, above all, medical monitoring and follow-up. Unfortunately, there are many cases of self-medication in Peru and Bolivia that require prompt management. Objective: To carry out a systematic review of the scientific literature that presents evidence about the effectiveness and adverse reactions of the drugs currently used against COVID-19 in Peru and Bolivia. Methods: Qualitative research based on the systematic review of the scientific literature available in PubMed, as well as in the national regulations of Peru and Bolivia related to the etiology, epidemiology, symptoms, as well as treatments approved and discontinued by both countries since the exacerbation of the COVID-19 crisis and the completion of clinical studies to date. Conclusions: The drugs used in Peru and Bolivia for treating COVID-19 have side effects and possible risks to the health of people who unfortunately self-medicate. Greater control of these drugs is required to avoid their free acquisition, and to improve the national and regional strategy to evaluate the possible symptomatic treatments of COVID-19, taking into consideration the high probability of survival of the disease and the risk posed by using these drugs, which, in the future, could cause serious adverse effects on public health in the two countries.
Treatment of COVID-19 in peru and bolivia, and self-medication risks
(Peruvian University of Applied Sciences, 2020) Brenda Rojas Román; Stephanie Moscoso; Sun Ah Chung; Bianca Limpias Terceros; Aldo Álvarez-Risco; Jaime A. Yáñez
Introduction: Various drugs are being used against the symptoms caused by COVID-19, without being approved for these purposes. Many of these drugs have small safety margin and very risky adverse effects on health, a reason why they require prescription and, above all, medical monitoring and follow-up. Unfortunately, there are many cases of self-medication in Peru and Bolivia that require prompt management. Objective: To carry out a systematic review of the scientific literature that presents evidence about the effectiveness and adverse reactions of the drugs currently used against COVID-19 in Peru and Bolivia. Methods: Qualitative research based on the systematic review of the scientific literature available in PubMed, as well as in the national regulations of Peru and Bolivia related to the etiology, epidemiology, symptoms, as well as treatments approved and discontinued by both countries since the exacerbation of the COVID-19 crisis and the completion of clinical studies to date. Conclusions: The drugs used in Peru and Bolivia for treating COVID-19 have side effects and possible risks to the health of people who unfortunately self-medicate. Greater control of these drugs is required to avoid their free acquisition, and to improve the national and regional strategy to evaluate the possible symptomatic treatments of COVID-19, taking into consideration the high probability of survival of the disease and the risk posed by using these drugs, which, in the future, could cause serious adverse effects on public health in the two countries.